EFPIA Newsletter 27 April 2023

EFPIA responses to the EU pharma legislation and patent package proposal     EU pharma-legislation risks sabotaging Europe’s life science industry putting European... 26 April 2023   The publication of the EU pharmaceutical legislation is an important milestone as the EU, Member States and industry strive to improve access to medicines and vaccines, and reinvigorate science and innovation in Europe. Unfortunately, this week's proposal manages to undermine research and development in Europe while failing to address access to medicines for patients. Read the full EFPIA response to the publication of the EU pharma legislation. Read more →       EFPIA response to the European Commission’s patent package proposal 27 April 2023   Following proposals that will weaken the EU’s intellectual property framework in yesterday’s EU Pharmaceutical Legislation [26 April 2023], today’s release of the patent package proposal provides some positives, but also considerable concerns and uncertainty for companies operating in the region. Read the full EFPIA response to the European Commission’s patent package proposal. Read more →

News     27 April 2023 IHI seeks patients and caregivers to contribute to its activities IHI is calling on patients and informal caregivers to apply to be part of a new IHI Patient Pool which will strengthen... Read more →

Events     28 APR 2023   Faster, more equitable access to medicines across Europe (1) Virtual event We believe that faster, more equitable access in Europe is an achievable goal. It requires a shared understanding of... Learn more →       11 MAY 2023   Webinar on the IHI Patient Pool Virtual IHI will hold a webinar on the Patient Pool. This webinar is designed to help potential applicants prepare their expression... Learn more →

	30 MAY 2023			Realising the potential of the European Health Data Space for Innovation Residence Palace, Rue de la Loi 155, 1040 Brussels EFPIA and COPAC are pleased to invite you to an in-person discussion on the key issues that are fundamental in ensuring... Learn more →

	22 JUN 2023			How the pharmaceutical industry is working to avoid and replace the use of animals... Zoom An online event co-organised by EFPIA and the RSPCA Learn more →

What we are reading It’s time that Europe makes up for lost ground in biopharmaceutical innovation 21 April 2023  (Farmaindustria) Read more → Mandatory application of the CTR in the EU 26 April 2023  (EMA) Read more → EPF TURNS 20 28 April 2023  (EPF) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe